Atlanta Braves Holdings officer reports 7,660 RSU vesting, share sale

Atlanta Braves Holdings, Inc.'s EVP, CLO & Secretary reported vesting of restricted stock units and a related share sale in Series C common stock.

Accepted by SEC EDGAR 12/15/2025 - 04:03 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc.'s EVP, CLO & Secretary reported vesting of restricted stock units and a related share sale in Series C common stock.

On December 11, 2025, 7,660 restricted stock units converted into 7,660 shares of Series C common stock at $0, resulting in 30,164 shares directly owned. On December 12, 2025, the officer sold 7,423 shares at a weighted average price of $39.71, in part to cover tax withholding obligations, and afterward held 22,741 Series C shares and 7,661 restricted stock units.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Heller Gregory John

Role EVP, CLO & Secretary

Sold 7,423 shs ($295K)

Approx. gross sale proceeds $295K

Approx. exercise cost $0.00

Share of Position Sold 24.6%

Type	Security	Shares	Price	Value
Sale	Series C Common Stock	7,423	$39.71	$295K
Exercise	Restricted Stock Units - BATRK	7,660	$0.00	$0.00
Exercise	Series C Common Stock	7,660	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units - BATRK — 7,661 contracts (Direct); Series C Common Stock — 22,741 shares (Direct)

Holdings Before and After: Restricted Stock Units - BATRK, 15,321 to 7,661 contracts (Direct); Series C Common Stock, 22,504 to 22,741 shares (Direct)

Other Insiders: 5 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (5)

1. F1. Each restricted stock unit converted into one share of Series C Common Stock.
2. F2. The sale reported on this Form 4 represents shares sold by the reporting person in part to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
3. F3. Reflects the weighted average sale price. The range of prices for such transaction is $39.36 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
4. F4. Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.
5. F5. One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did the Atlanta Braves Holdings (BATRA) EVP, CLO & Secretary report?

The EVP, CLO & Secretary of Atlanta Braves Holdings, Inc. reported the vesting of restricted stock units into Series C common stock and a subsequent sale of some of those shares. The transactions occurred on December 11 and December 12, 2025.

How many Atlanta Braves Holdings Series C shares were acquired through RSU vesting?

On December 11, 2025, 7,660 restricted stock units converted into 7,660 shares of Atlanta Braves Holdings Series C common stock, with each unit converting into one share.

How many Atlanta Braves Holdings shares were sold and at what price?

On December 12, 2025, the officer sold 7,423 shares of Series C common stock at a weighted average price of $39.71, with individual sale prices ranging from $39.36 to $40.12.

Why were some shares of Atlanta Braves Holdings stock sold after the RSU vesting?

The filing states that the sale of shares reported was made in part to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

What are the executive's holdings after these transactions in Atlanta Braves Holdings stock?

After the reported transactions, the officer directly owned 22,741 shares of Series C common stock and held 7,661 restricted stock units tied to additional potential Series C shares.

When do the remaining restricted stock units for the Atlanta Braves Holdings executive vest?

According to the filing, one-third of the restricted stock unit award vested on each of December 11, 2024 and December 11, 2025, and the remaining restricted stock units vest on December 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Heller Gregory John

(Last) (First) (Middle)

C/O ATLANTA BRAVES HOLDINGS, INC.

755 BATTERY AVENUE SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Atlanta Braves Holdings, Inc. [ BATRK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CLO & Secretary

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series C Common Stock	12/11/2025		M		7,660	A	$0(1)	30,164	D
Series C Common Stock	12/12/2025		S(2)		7,423	D	$39.71(3)	22,741	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units - BATRK	(4)	12/11/2025		M			7,660	(5)	(5)	Series C Common Stock	7,660	$0	7,661	D

Explanation of Responses:

1. Each restricted stock unit converted into one share of Series C Common Stock.

2. The sale reported on this Form 4 represents shares sold by the reporting person in part to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

3. Reflects the weighted average sale price. The range of prices for such transaction is $39.36 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

4. Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

5. One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

	/s/ Kerry T. Wenzel, Attorney-in-Fact	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.